Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 457.0
(-2.35%)
JPY 457.0
(-2.35%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - JPY | -100.0% |
| 2022 | 133 Thousand JPY | -85.79% |
| 2021 | 936 Thousand JPY | -46.21% |
| 2020 | 1.74 Million JPY | -42.88% |
| 2019 | 3.04 Million JPY | -51.19% |
| 2018 | 6.24 Million JPY | -20.97% |
| 2017 | 7.89 Million JPY | -45.77% |
| 2016 | 14.56 Million JPY | -34.47% |
| 2015 | 22.22 Million JPY | -16.6% |
| 2014 | 26.64 Million JPY | -95.26% |
| 2013 | 562.09 Million JPY | 7.67% |
| 2012 | 522.05 Million JPY | -34.89% |
| 2011 | 801.8 Million JPY | -23.25% |
| 2010 | 1.04 Billion JPY | -18.88% |
| 2009 | 1.28 Billion JPY | 69.43% |
| 2008 | 760.12 Million JPY | 33.99% |
| 2007 | 567.31 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - JPY | 0.0% |
| 2024 Q2 | - JPY | 0.0% |
| 2023 Q1 | - JPY | -100.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 FY | - JPY | -100.0% |
| 2023 Q2 | - JPY | 0.0% |
| 2023 Q4 | - JPY | 0.0% |
| 2022 Q4 | 133 Thousand JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2022 Q1 | - JPY | -100.0% |
| 2022 FY | 133 Thousand JPY | -85.79% |
| 2021 Q4 | 936 Thousand JPY | 180.24% |
| 2021 Q3 | 334 Thousand JPY | -37.57% |
| 2021 Q2 | 535 Thousand JPY | -27.31% |
| 2021 Q1 | 736 Thousand JPY | -57.7% |
| 2021 FY | 936 Thousand JPY | -46.21% |
| 2020 FY | 1.74 Million JPY | -42.88% |
| 2020 Q2 | - JPY | 0.0% |
| 2020 Q3 | - JPY | 0.0% |
| 2020 Q4 | 1.74 Million JPY | 0.0% |
| 2020 Q1 | - JPY | -100.0% |
| 2019 Q1 | - JPY | -100.0% |
| 2019 Q2 | - JPY | 0.0% |
| 2019 Q3 | - JPY | 0.0% |
| 2019 FY | 3.04 Million JPY | -51.19% |
| 2019 Q4 | 3.04 Million JPY | 0.0% |
| 2018 FY | 6.24 Million JPY | -20.97% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q1 | - JPY | -100.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2018 Q4 | 6.24 Million JPY | 0.0% |
| 2017 Q4 | 7.89 Million JPY | 0.0% |
| 2017 FY | 7.89 Million JPY | -45.77% |
| 2017 Q3 | - JPY | 0.0% |
| 2017 Q2 | - JPY | 0.0% |
| 2017 Q1 | - JPY | -100.0% |
| 2016 FY | 14.56 Million JPY | -34.47% |
| 2016 Q2 | - JPY | 0.0% |
| 2016 Q3 | - JPY | 0.0% |
| 2016 Q4 | 14.56 Million JPY | 0.0% |
| 2016 Q1 | - JPY | -100.0% |
| 2015 Q1 | - JPY | -100.0% |
| 2015 FY | 22.22 Million JPY | -16.6% |
| 2015 Q4 | 22.22 Million JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2014 Q3 | 725.8 Million JPY | -3.41% |
| 2014 Q2 | 751.4 Million JPY | 32.56% |
| 2014 FY | 26.64 Million JPY | -95.26% |
| 2014 Q1 | 566.83 Million JPY | 0.84% |
| 2014 Q4 | 26.64 Million JPY | -96.33% |
| 2013 Q3 | 606.18 Million JPY | -7.17% |
| 2013 FY | 562.09 Million JPY | 7.67% |
| 2013 Q2 | 653.03 Million JPY | 36.95% |
| 2013 Q4 | 562.09 Million JPY | -7.27% |
| 2013 Q1 | 476.83 Million JPY | -8.66% |
| 2012 Q2 | 670.98 Million JPY | -11.41% |
| 2012 Q1 | 757.43 Million JPY | -5.53% |
| 2012 Q3 | 601.47 Million JPY | -10.36% |
| 2012 Q4 | 522.05 Million JPY | -13.2% |
| 2012 FY | 522.05 Million JPY | -34.89% |
| 2011 Q2 | 917.98 Million JPY | -8.5% |
| 2011 Q3 | 894.72 Million JPY | -2.53% |
| 2011 Q4 | 801.8 Million JPY | -10.39% |
| 2011 FY | 801.8 Million JPY | -23.25% |
| 2011 Q1 | 1 Billion JPY | -3.97% |
| 2010 Q2 | 1.49 Billion JPY | -3.27% |
| 2010 FY | 1.04 Billion JPY | -18.88% |
| 2010 Q3 | 1.14 Billion JPY | -23.22% |
| 2010 Q4 | 1.04 Billion JPY | -9.06% |
| 2010 Q1 | 1.54 Billion JPY | 20.09% |
| 2009 Q4 | 1.28 Billion JPY | -4.67% |
| 2009 Q2 | 1.34 Billion JPY | 4.64% |
| 2009 Q1 | 1.28 Billion JPY | 69.11% |
| 2009 Q3 | 1.35 Billion JPY | 0.44% |
| 2009 FY | 1.28 Billion JPY | 69.43% |
| 2008 Q4 | 760.12 Million JPY | 47.52% |
| 2008 FY | 760.12 Million JPY | 33.99% |
| 2008 Q3 | 515.26 Million JPY | 0.0% |
| 2007 FY | 567.31 Million JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | 100.0% |
| PRISM BioLab Co.,LTD | - JPY | NaN% |
| GNI Group Ltd. | 3.69 Billion JPY | 100.0% |
| Linical Co., Ltd. | 3 Billion JPY | 100.0% |
| Trans Genic Inc. | 2.25 Billion JPY | 100.0% |
| MEDINET Co., Ltd. | 2.3 Million JPY | 100.0% |
| Soiken Holdings Inc. | - JPY | NaN% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | 100.0% |
| AnGes, Inc. | 362.67 Million JPY | 100.0% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | 100.0% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 100.0% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | 100.0% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 100.0% |
| Carna Biosciences, Inc. | 182.97 Million JPY | 100.0% |
| CanBas Co., Ltd. | - JPY | NaN% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | 100.0% |
| RaQualia Pharma Inc. | 367.71 Million JPY | 100.0% |
| Chiome Bioscience Inc. | 291 Million JPY | 100.0% |
| Kidswell Bio Corporation | 2.57 Billion JPY | 100.0% |
| PeptiDream Inc. | 22.79 Billion JPY | 100.0% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | 100.0% |
| Ribomic Inc. | - JPY | NaN% |
| SanBio Company Limited | 665 Million JPY | 100.0% |
| Healios K.K. | 4.53 Billion JPY | 100.0% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | 100.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | 100.0% |
| Delta-Fly Pharma, Inc. | - JPY | NaN% |
| StemRIM | - JPY | NaN% |
| CellSource Co., Ltd. | 97.54 Million JPY | 100.0% |
| FunPep Company Limited | - JPY | NaN% |
| Kringle Pharma, Inc. | - JPY | NaN% |
| Stella Pharma Corporation | 933.3 Million JPY | 100.0% |
| TMS Co., Ltd. | - JPY | NaN% |
| Noile-Immune Biotech Inc. | - JPY | NaN% |
| Cuorips Inc. | - JPY | NaN% |
| K Pharma,Inc. | - JPY | NaN% |
| Takara Bio Inc. | 968 Million JPY | 100.0% |
| ReproCELL Incorporated | - JPY | NaN% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | 100.0% |
| StemCell Institute Inc. | 8.78 Million JPY | 100.0% |
| CellSeed Inc. | 151.25 Million JPY | 100.0% |